Heart Health Ingredients: A Global Strategic Business Report
San Jose, California (PRWEB) August 16, 2012
Follow us on LinkedIn – There has been a steep rise in the incidence of heart health related disorders in the past few years, primarily due to changing eating patterns among consumers. Increased consumption of salt, saturated foods and fatty acids along with alcohol are some of the leading factors influencing the higher incidence of heart disorders. In Europe, cardiovascular related deaths grew to about 50% of the female population and nearly 40% of the male population. Japan, traditionally known for low cardiovascular death rates, has also showed sharp increase in cardiovascular related deaths in recent years. World over, population with heart disorders is on an upward spiral.
Rising heart disorder induced mortality figures are creating the need for healthy eating even more conspicuous. In this context, food products laden with heart health ingredients are gaining high attention due to their potentiality in reducing cholesterol levels, thereby improving heart health. During the past few years, products such as fish oils, flaxseed oils, algae oil, tofu, soy protein based products and various other functional foods demonstrated a robust improvement in their sales. Soy Protein emerged as the key heart health ingredient. Phytosterols, beta-glucagon, and omega-3 are the other major segments performing well in the market. Heart health ingredients commonly find application in dairy products, cereals, and beverages.
Natural heart health ingredients are the latest trend among health conscious consumers. The relatively new natural ingredients including polymethoxylated flavones (PMFs), pomegranate, and tocotrienols of the vitamin E family are gaining prominence and are set to revolutionize the heart health ingredients market. Found in peels of citrus fruits including oranges, PMFs belong to a special class of flavonoids that minimize cholesterol levels. Tocotrienols, found in rice and palm oil, help in reduction of cholesterol by limiting the activity of enzymes responsible for cholesterol generation inside the liver.
Alongside the favorable projections, heart health ingredients market struggles to cope with some major barriers. Lack of comprehensive scientific data continues to hinder the full-scale growth of the heart health products. Product recalls and new evidences offsetting the credibility of the already marketed product are resulting in widespread confusion among consumers. Further, product pricing is another factor that deters consumers from buying such products. In a nutshell, factors including price constraints, supply-side issues, and lack of comprehensive scientific evidences strengthening the health claims are poised to play a crucial role in shaping up the market in the coming years.
Regulations or lack of it significantly affect the functional foods market. For example, the FOSHU regulations acted as a key catalyst in functional food market growth in Japan. The United States Food and Drug Authority (USFDA) and the European Food Safety Authority (EFSA) are focused on adopting more active role in the functional foods area. In 2009, the EFSA released a report reveling 2/3rds of the 500 applications for functional food health claims are not in line with the standards. Likewise, the USFDA unveiled a manual for the entire nutritional food segment. Regulatory scenario holds the key in transforming the market along clear lines and infusing confidence among consumers.
As stated by the new market research report on Heart Health Ingredients, Asia-Pacific represents the most prominent regional market in the world with a CAGR of about 15% over the analysis period. Characterized by low labor costs, Asia-Pacific represents the highly established market for heart health ingredients. The region competes vigorously with western markets including the US and Europe, with Asian manufacturers playing an active role.
Major players in the global marketplace include Archer Daniels Midland Company, BASF SE, BioActives LLC, Biovelop AB, Cargill Inc., Cyanotech Corporation, DSM Nutritional Products Limited, Glanbia Nutritionals Inc., Lonza Group Limited, LycoRed Limited, Martek Biosciences Corporation, Novus Nutrition Brands LLC, Ocean Nutrition Canada Limited, Omega Protein Corporation, Pharmachem Laboratories Inc., Proprietary Nutritionals Inc., Raisio Plc, Solae Europe S.A., Soy Labs LLC, and Valensa International LLC.
The research report titled “Heart Health Ingredients: A Global Strategic Business Report” announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, issues, drivers, company profiles, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections in US$ million for product segments Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients across geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK and Rest of Europe), Asia-Pacific and Rest of World.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/